Subsidiary of Zhejiang Orient Gene Biotech (688298.SH) obtains medical device registration certificate.
Dongfang Biology (688298.SH) has issued an announcement, stating that its subsidiary Shanghai Huizijian Biological Technology Co., Ltd. and He...
Zhejiang Orient Gene Biotech (688298.SH) has announced that its subsidiary, Shanghai Wanzijian Biotechnology Co., Ltd. and Healgen Scientific LLC (referred to as "American Healgen"), have obtained medical device registration certificates for multiple products in China, Australia, and Singapore recently.
The above-mentioned registered products have enriched the company's flow cytometry technology platform product range. The respiratory tract three-in-one test product has expanded the international market for sale, which is beneficial for the overall expansion of related products in domestic and foreign markets.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


